A genome scan for ESRD in black families enriched for nondiabetic nephropathy

Journal of the American Society of Nephrology

Volumn 15, Issue 10, 2004, Pages 2719-2727

  Freedman, Barry I ^a   Langefeld, Carl D ^a   Rich, Stephen S ^a   Valis, Christopher J ^a   Sale, Michèle M ^a   Williams, Adrienne H ^a   Brown, W Mark ^a   Beck, Stephanie R ^a   Hicks, Pamela J ^a   Bowden, Donald W ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PODOCIN;

ARTICLE; BODY MASS; CHROMOSOME 13Q; CHROMOSOME 14Q; CHROMOSOME 18P; CHROMOSOME 1Q; CHROMOSOME 20Q; CHROMOSOME 5P; CHROMOSOME 6P; CHROMOSOME 8P; CHROMOSOME 9P; DIABETIC NEPHROPATHY; FAMILY; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOME; HEALTH HAZARD; HUMAN; HYPERTENSION; KIDNEY FAILURE; NEGRO; PEDIGREE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SIBLING; ADULT; AGE DISTRIBUTION; AGED; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; FEMALE; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HOSPITALIZATION; INCIDENCE; MALE; MIDDLE AGED; OBESITY; PROGNOSIS; RENAL REPLACEMENT THERAPY; RISK; RISK ASSESSMENT; SEX RATIO; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BODY MASS INDEX; COHORT STUDIES; COMORBIDITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOME; HUMANS; HYPERTENSION; INCIDENCE; KIDNEY FAILURE, CHRONIC; LINKAGE (GENETICS); LOD SCORE; MALE; MIDDLE AGED; NORTH CAROLINA; OBESITY; ODDS RATIO; PEDIGREE; PROGNOSIS; REGRESSION ANALYSIS; RENAL DIALYSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 16644377847     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000141312.39483.4F     Document Type: Article

References (44)

1. U.S. Renal Data System: USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003
2. Southeastern Kidney Council, ESRD Network 6: 2000 Annual Report. Raleigh, Southeastern Kidney Council, 2000
3. Bleyer AJ, Appel RG: Risk factors associated with hypertensive nephrosclerosis. Nephron 82: 193-198, 1999
4. Whittle JC, Whelton PK, Seidler AL, Klag MJ: Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? Arch Intern Med 151: 1359-1364, 1991
5. McClellan W, Tuttle E, Issa A: Racial differences in the incidence of hypertensive end-stage renal disease are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis 12: 285-290, 1988
6. Sclessinger SD, Tankersley MR, Curtis J: Hypertensive end-stage renal disease: Where's the proof? Am J Kidney Dis 23: 655-660, 1994
7. Perneger TV, Whelton PK, Klag MJ, Rossiter KA: Diagnosis of hypertensive end-stage renal disease: Effect of the patient's race. Am J Epidemiol 141: 10-15, 1995
8. Zarif L, Covic A, Iyengar S, Sehgal AR, Sedor JR, Schelling JR: Inaccuracy of clinical phenotyping parameters for hypertensive nephrosclerosis. Nephrol Dial Transplant 15: 1801-1807, 2000
9. Fogo A, Breyer JA, Smith MC, Cleveland WH, Agodoa L, Kirk KA, Glassock R. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans Study, Kidney Disease (AASK) Trial. AASK Pilot Study Investigators. Kidney Int 51: 244-252
10. Marcantoni C, Ma LJ, Federspiel C, Fogo AB: Hypertensive nephrosclerosis in African Americans versus Caucasians. Kidney Int 62: 172-180, 2002
11. Freedman BI: End-stage renal failure in African Americans: Insights in kidney disease susceptibility. Nephrol Dial Transplant 17: 198-200, 2002
12. Neaton JD, Kuller LH, Wentworth D, Borhani NO: Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years. Am Heart J 109: 759-769, 1984
13. Shulman NB, Ford CE, Hall D, Blaufox D, Simon D, Lanford HG, Schneider KA: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Hypertension 13[Supp 1]: S80-S93, 1989
14. Wright JT Jr, Bakris G, Greene T, Agadoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG; African American Study of Kidney Disease and Hypertension Study Group: Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 288: 2421-2431, 2002
15. Freedman BI, Spray BJ, Tuttle AB, Buckalew VM: The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis 21: 387-393, 1993
16. Satko SG, Freedman BI: The familial clustering of renal disease and related phenotypes. Med Clin N Am 2004, in press
17. Yu H, Bowden DW, Spray BJ, Rich SS, Freedman BI: Linkage analysis between loci in the renin-angiotensin axis and end-stage renal disease in African Americans. J Am Soc Nephrol 7: 2559-2564, 1996
18. Freedman BI, Yu H, Spray BJ, Rich SS, Rothschild CB, Bowden DW: Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans. Kidney Int 51: 819-825, 1997
19. Yu H, Bowden DW, Spray BJ, Rich SS, Freedman BI: Identification of human plasma kallikrein gene polymorphisms and evaluation of their role in end-stage renal disease. Hypertension 31: 906-911, 1998
20. Yu H, Anderson PJ, Freedman BI, Rich SS, Bowden DW: Genomic structure of the human plasma prekallikrein gene, identification of allelic variants, and analysis in end-stage renal disease. Genomics 69: 225-234, 2000
21. Freedman BI, Yu H, Anderson PJ, Roh BH, Rich SS, Bowden DW: Genetic analysis of nitric oxide and endothelin in end-stage renal disease. Nephrol Dial Transplant 15: 1794-1800, 2000
22. Freedman BI, Rich SS, Yu H, Roh BH, Bowden DW: Linkage heterogeneity of end-stage renal disease on human chromosome 10. Kidney Int 62: 770-774, 2002
23. McPeek MS, Sun L: Statistical tests for detection of misspecified relationships by use of genome-screen data. Am J Hum Genet 66: 1076-1094, 2000
24. O'Connell JR, Weeks DE: PedCheck. A program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 63: 259-266, 1998
25. Broman KW, Murray JC, Sheffield VC, White RL, Weber JL: Comprehensive human genetic maps: Individual and sex-specific variation in recombination. Am J Hum Genet 63: 861-869, 1998
26. Sale MM, Freedman BI, Langefeld CD, Williams AH, Hicks PJ, Colicigno CJ, Beck SR, Brown WM, Rich SS, Bowden DW: A genome-wide scan for type 2 diabetes in African American families reveals a locus on chromosome 6q. Diabetes 53: 830-837, 2004
27. Bowden DW, Colicigno CJ, Langefeld CD, Sale MM, Williams A, Anderson PJ, Rich SS, Freedman BI: A genome scan for diabetes-associated end-stage renal disease in African Americans. Kidney Int 66: 2004, (in press)
28. Langefeld CD: The Application of Statistical Methods for Highly Stratified Data to Linkage and Association Analyses of Complex Genetic Traits. Ann Arbor, University of Michigan, 1999
29. Langefeld CD, Boehnke M: Multiple trait locus nonparametric linkage regression. Am J Hum Genet 65: A1140, 1999
30. Langefeld CD, Davis CC, Brown WM: Nonparametric linkage regression. I: Combined Caucasian CSGA and German genome scans for asthma. Genet Epidemiol 21[Suppl 1]: S136-S141, 2001
31. Davis CC, Brown WM, Lange EM, Rich SS, Langefeld CD: Nonparametric linkage regression. II. Identification of influential pedigrees in tests for linkage. Genet Epidemiol 21[Suppl 1]: S123-S129, 2001
32. Whittemore AS, Halpern J: A class of tests for linkage using affected pedigree members. Biometrics 50: 118-127, 1994
33. Hauser ER, Watanabe RM, Duren WL, Li C, Langefeld CD, Boenke M: Ordered subset analysis in genetic linkage mapping of complex traits. Am J Human Genet 27: 53-63, 2004
34. Freedman BI, Iskandar SS, Appel RG: The link between hypertension and nephrosclerosis. Am J Kidney Dis 25: 207-221, 1995
35. Simon B, Farhi A, Mahnensmith R, Lifton RP: Inherited susceptibility to HIV nephropathy in African Americans [Abstract]. J Am Soc Nephrol 7: 1343, 1996
36. Gumprecht J, Zychma MJ, Moczulski DK, Gosek K, Grzeszczak W: Family history of end-stage renal disease among hemodialyzed patients in Poland. J Nephrol 16: 511-515, 2003
37. Verani RR: Obesity-associated focal segmental glomerulosclerosis: Pathological features of the lesion and relationship with cardiomegaly and hyperlipidemia. Am J Kidney Dis 20: 629-634, 1992
38. Lackland DT, Egan BM, Fan ZJ, Syddall HE: Low birth weight contributes to the excess prevalence of end-stage renal disease in African Americans. J Clin Hypertension 3: 29-31, 2001
39. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, Mat BJ, Rodriguez-Perez JC, Allen PG, Beggs AH, Pollak MR: Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 24:251-156, 2000
40. Tsukaguchi H, Yager H, Dawborn J, Jost L, Cohlmia J, Abreu PF, Pereia AB, Pollak MR: A locus for adolescent and adult onset familial focal segmental glomerulosclerosis on chromosome 1q25-31. J Am Soc Nephrol 11: 1674-1680, 2000
41. Rana K, Isbel N, Buzza M, Dagher H, Henning P, Kainer G, Savige J: Clinical, histopathologic, and genetic studies in nine families with focal segmental glomerulosclerosis. Am J Kidney Dis 41: 1170-1178, 2003
42. Winn MP, Conlon PJ, Lynn KL, Howell DN, Slotterbeck BD, Smith AH, Graham FL, Bembe M: Quarles LD, Pericak-Vance MA, Vance JM: Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneity. Genomics 58: 113-120, 1999
43. Moczulski DK, Rogus JJ, Antonellis A, Warram JH, Krolewski AS: Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: Results of novel discordant sib-pair analysis. Diabetes 47: 1164-1169, 1998
44. Vardarli I, Baier LJ, Hanson RL, Akkoyun I, Fischer C, Rohmeiss P, Basci A, Bartram CR, Van Der Woude FJ, Janssen B: Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to chromosome 18q22.3-23. Kidney Int 62: 2176-2183, 2002